Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-002177

SVP, Chief Technical Officer gave up 3,044 shares (to pay taxes)

  • SVP, Chief Technical Officer acquired 8,803 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LaBarre Michael J. · SVP, Chief Technical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-02-22 Exercise or conversion : show line 1 in the form +8,803 179,231 D
2020-02-22 Shares withheld for taxes : show line 2 in the form −3,044 $21.83 $66,451 176,187 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Underlying Owned after D/I
2020-02-22 Exercise or conversion : show line 3 in the form Restricted Stock Units −8,803 $0.00 8,803 8,803 D
Loading xslF345X03/edgar.xml…